• 5456 Citations
  • 40 Scopus h-Index
20032019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sumithra J Mandrekar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 23 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Survival Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2018

Research Output 2003 2019

Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia

Ruppert, A. S., Yin, J., Davidian, M., Tsiatis, A. A., Byrd, J. C., Woyach, J. A. & Mandrekar, S. J., Apr 1 2019, In : Annals of oncology : official journal of the European Society for Medical Oncology. 30, 4, p. 542-550 9 p.

Research output: Contribution to journalArticle

Open Access
B-Cell Chronic Lymphocytic Leukemia
Maintenance
PCI 32765
Residual Neoplasm
Sample Size

Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)

Yin, J., Laplant, B., Uy, G. L., Marcucci, G., Blum, W., Larson, R. A., Stone, R. M. & Mandrekar, S. J., Jun 11 2019, In : Blood Advances. 3, 11, p. 1714-1721 8 p.

Research output: Contribution to journalArticle

Open Access
Acute Myeloid Leukemia
Disease-Free Survival
Cell Transplantation
Random Allocation
Endpoint Determination
3 Citations (Scopus)
Phase I Trial
End point
Toxicity
Binary
Dose

Ibrutinib Regimens in Older Patients with Untreated CLL. Reply

Woyach, J. A., Ruppert, A. S. & Mandrekar, S. J., Apr 25 2019, In : The New England journal of medicine. 380, 17, p. 1680-1681 2 p.

Research output: Contribution to journalLetter

Pyrazoles
Pyrimidines
PCI 32765

Improving attribution of adverse events in oncology clinical trials

George, G. C., Barata, P. C., Campbell, A., Chen, A., Cortes, J. E., Hyman, D. M., Jones, L., Karagiannis, T., Klaar, S., Le-Rademacher, J., LoRusso, P., Mandrekar, S. J., Merino, D. M., Minasian, L. M., Mitchell, S. A., Montez, S., O'Connor, D. J., Pettit, S., Silk, E., Sloan, J. A. & 6 others, Stewart, M., Takimoto, C. H., Wong, G. Y., Yap, T. A., Cleeland, C. S. & Hong, D. S., Jun 1 2019, In : Cancer Treatment Reviews. 76, p. 33-40 8 p.

Research output: Contribution to journalReview article

Clinical Trials
Research Personnel
Causality
Translational Medical Research
Contracts